All those interested in the advances within the sector of therapeutic cannabis in Spain have much to celebrate these months. Finally there is an institution dedicated exclusively to the study and promotion of the medicinal properties of marijuana and its derivatives.
September 20 will be the date to present the Spanish Observatory of Medicinal Cannabis (OECM). A date to save in our agendas, as the assistants to the event could listen and learn from leading national and international experts in the study of the therapeutic properties of this plant.
The presentation will take place at the Auditorium of the Caixaforum in Madrid (Paseo del Prado, 36). It will unfold from 08.30 h to 17.30 h, with an extraordinary agenda divided into three main parts:
- Presentation of medical cannabis.
- Models of regulation of medical cannabis.
- Encounter with patients.
The presentation will be conducted by leading experts from different countries all over the world and renowned scientists who are studying the use of medicinal cannabis. Among them are professionals who, most likely, will enter as a part of the “History of Medicine”-books to be written in a near future, as it is the case of the Dr. Raphael Mechoulam from the Hebrew University of Jerusalem (Israel). Mechoulan chemically characterized for the first time the plant’s cannabinoids and endocannabinoids.
In the presentation will also intervene Ana María Gazmuri, from the prestigious Fundación DAYA (Chile), dedicated to the research and promotion of alternative therapies that ease human suffering. Paulina Bobadilla (Mama cultivates Chile), Carola Pérez (President of the OECM) and Manuel Guzmán are only some of the names that outline an outstanding panel. You can check them all out on the web of the OECM.
This will be the first time in Spain, where with absolute liberty, researchers, doctors and patients will meet with all those who are wishing to learn about the possible medicinal uses of cannabis. The afternoon session will be marked by the debate between patients and experts on diseases that had spread among global population recently. Among them are childhood epilepsy, cancer, inflammatory bowel disease, chronic pain and neurodegenerative diseases.
The OECM was born as a platform created by experts (researchers, doctors and patients associations) in order to provide evidence-based information and promote, coordinate, and carry out activities and projects aimed at understanding the properties and medicinal uses of cannabis and its derivatives. Its objectives are focused on train and inform about the therapeutic properties and the use of cannabis as a medicine.
Likewise, the OECM aims to advise public and private entities and inform institutions, media, patients and therapeutic users about the current knowledge on the properties and medicinal uses of cannabis and its derivatives, based on the results of scientific studies and clinical trials.